Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)

The Small Business Transition Grant for New Entrepreneurs is a forecasted federal funding opportunity from the National Institutes of Health and the Centers for Disease Control and Prevention. This program is designed to support early-career scientists as they transition into entrepreneurial roles within the small business sector. It operates under the Small Business Innovation Research framework using the R43 and R44 activity codes, which are traditionally structured to support phased research and development projects. The initiative reflects a broader federal priority to translate scientific innovation into commercial and public health impact by fostering new business leadership among emerging investigators. The primary purpose of this grant is to provide both financial support and structured entrepreneurial development for first-time principal investigators. In addition to funding research and development activities within a small business concern, the program emphasizes career development, mentorship, and training. A key distinguishing feature is the requirement for mentorship, ensuring that applicants receive guidance from experienced professionals with measurable involvement in the project. This dual focus on innovation and professional growth is intended to build sustainable entrepreneurial capacity within the biomedical and public health sectors. Funding under this opportunity will support research aligned with the missions of participating NIH and CDC institutes and centers. While specific allowable costs are not detailed in the forecast, typical SBIR Phase I and Fast-Track awards support feasibility studies, early-stage development, and initial commercialization planning. The absence of a cost-sharing requirement lowers the barrier to entry for new entrepreneurs. However, applicants should anticipate standard federal compliance requirements related to research integrity, reporting, and financial accountability. Eligibility is restricted to United States small business concerns as defined by the Small Business Administration. Applicants must demonstrate that the applying entity meets federal small business criteria and possesses the technical capabilities to execute the proposed research. Additionally, the principal investigator must be an early-career individual who has not previously served as an independent principal investigator on a qualifying research grant. Citizenship or lawful permanent residency is required for the principal investigator, reinforcing the program’s focus on developing domestic scientific entrepreneurship. The application process is not yet open, as this is a forecasted opportunity intended to provide advance notice. Prospective applicants are encouraged to begin preparing by identifying mentors, refining research concepts, and aligning their proposals with NIH and CDC priorities. Once released, the formal Notice of Funding Opportunity will outline submission procedures, required components, and evaluation criteria. Typically, SBIR applications require detailed research plans, commercialization strategies, and supporting documentation demonstrating feasibility and impact. The anticipated timeline indicates an estimated posting date in November 2026, with applications due in early January 2027. Awards are expected to be issued in mid-2027, with project activities beginning shortly thereafter. This structured timeline allows applicants several months of preparation following the official release. While the recurrence of this opportunity is not explicitly stated, similar NIH SBIR programs are often issued regularly, suggesting potential future cycles. Interested applicants should monitor official channels and maintain readiness for subsequent announcements. For additional information, applicants may contact the NIH SEED Office of Extramural Research via phone or email. This office provides guidance on small business programs, entrepreneurial development, and application preparation. Early engagement with program contacts is advisable to clarify eligibility, expectations, and strategic alignment prior to submission.